These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 27900261)

  • 21. Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome.
    Motaghedi R; Lipman EG; Hogg JE; Christos PJ; Vogiatzi MG; Angulo MA
    Eur J Med Genet; 2011; 54(1):14-8. PubMed ID: 20965292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoid-1 Receptor Antagonism Improves Glycemic Control and Increases Energy Expenditure Through Sirtuin-1/Mechanistic Target of Rapamycin Complex 2 and 5'Adenosine Monophosphate-Activated Protein Kinase Signaling.
    Liu J; Godlewski G; Jourdan T; Liu Z; Cinar R; Xiong K; Kunos G
    Hepatology; 2019 Apr; 69(4):1535-1548. PubMed ID: 30506571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fat-Free Mass Is Better Related to Serum Uric Acid Than Metabolic Homeostasis in Prader-Willi Syndrome.
    Marzullo P; Mele C; Minocci A; Mai S; Scacchi M; Sartorio A; Aimaretti G; Grugni G
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854398
    [No Abstract]   [Full Text] [Related]  

  • 24. The imprinted gene Magel2 regulates normal circadian output.
    Kozlov SV; Bogenpohl JW; Howell MP; Wevrick R; Panda S; Hogenesch JB; Muglia LJ; Van Gelder RN; Herzog ED; Stewart CL
    Nat Genet; 2007 Oct; 39(10):1266-72. PubMed ID: 17893678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
    Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
    J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magel2 knockout mice manifest altered social phenotypes and a deficit in preference for social novelty.
    Fountain MD; Tao H; Chen CA; Yin J; Schaaf CP
    Genes Brain Behav; 2017 Jul; 16(6):592-600. PubMed ID: 28296079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired melanocortin pathway function in Prader-Willi syndrome gene-Magel2 deficient mice.
    Oncul M; Dilsiz P; Ates Oz E; Ates T; Aklan I; Celik E; Sayar Atasoy N; Atasoy D
    Hum Mol Genet; 2018 Sep; 27(18):3129-3136. PubMed ID: 29878108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational Approach.
    Valenta I; Varga ZV; Valentine H; Cinar R; Horti A; Mathews WB; Dannals RF; Steele K; Kunos G; Wahl RL; Pomper MG; Wong DF; Pacher P; Schindler TH
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):320-332. PubMed ID: 29413441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism.
    Meziane H; Schaller F; Bauer S; Villard C; Matarazzo V; Riet F; Guillon G; Lafitte D; Desarmenien MG; Tauber M; Muscatelli F
    Biol Psychiatry; 2015 Jul; 78(2):85-94. PubMed ID: 25599930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity.
    Tam J; Vemuri VK; Liu J; Bátkai S; Mukhopadhyay B; Godlewski G; Osei-Hyiaman D; Ohnuma S; Ambudkar SV; Pickel J; Makriyannis A; Kunos G
    J Clin Invest; 2010 Aug; 120(8):2953-66. PubMed ID: 20664173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline anandamide levels and body weight impact the weight loss effect of CB1 receptor antagonism in male rats.
    Karlsson C; Hjorth S; Karpefors M; Hansson GI; Carlsson B
    Endocrinology; 2015 Apr; 156(4):1237-41. PubMed ID: 25549047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome.
    Salehi P; Hsu I; Azen CG; Mittelman SD; Geffner ME; Jeandron D
    Pediatr Obes; 2017 Jun; 12(3):221-228. PubMed ID: 27071367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of MAGEL2 in Prader-Willi syndrome leads to decreased secretory granule and neuropeptide production.
    Chen H; Victor AK; Klein J; Tacer KF; Tai DJ; de Esch C; Nuttle A; Temirov J; Burnett LC; Rosenbaum M; Zhang Y; Ding L; Moresco JJ; Diedrich JK; Yates JR; Tillman HS; Leibel RL; Talkowski ME; Billadeau DD; Reiter LT; Potts PR
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32879135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.
    Sze L; Purtell L; Jenkins A; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1314-9. PubMed ID: 21632815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.
    Sun LJ; Yu JW; Wan L; Zhang XY; Shi YG; Chen MY
    Int J Infect Dis; 2014 Jun; 23():75-81. PubMed ID: 24704332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocannabinoids exert CB
    Xu C; Hermes DJ; Nwanguma B; Jacobs IR; Mackie K; Mukhopadhyay S; Lichtman AH; Ignatowska-Jankowska B; Fitting S
    Mol Cell Neurosci; 2017 Sep; 83():92-102. PubMed ID: 28733129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced Endotoxemia.
    Santos-Molina L; Herrerias A; Zawatsky CN; Gunduz-Cinar O; Cinar R; Iyer MR; Wood CM; Lin Y; Gao B; Kunos G; Godlewski G
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of 1-(2,4-dichlorophenyl)-N-(piperidin-1-yl)-4-((pyrrolidine-1-sulfonamido)methyl)-5-(5-((4-(trifluoromethyl)phenyl)ethynyl)thiophene-2-yl)-1H-pyrazole-3-carboxamide as a novel peripherally restricted cannabinoid-1 receptor antagonist with significant weight-loss efficacy in diet-induced obese mice.
    Chang CP; Wu CH; Song JS; Chou MC; Wong YC; Lin Y; Yeh TK; Sadani AA; Ou MH; Chen KH; Chen PH; Kuo PC; Tseng CT; Chang KH; Tseng SL; Chao YS; Hung MS; Shia KS
    J Med Chem; 2013 Dec; 56(24):9920-33. PubMed ID: 24224693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.
    Correa-da-Silva F; Fliers E; Swaab DF; Yi CX
    J Neuroendocrinol; 2021 Jul; 33(7):e12994. PubMed ID: 34156126
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Choi Y; Min HY; Hwang J; Jo YH
    Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 36007929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.